1235036-15-3

Basic information

• Product Name: Tert-butyl 3-bromo-6-chloropicolinate
• Synonyms: Tert-butyl 3-bromo-6-chloropicolinate;2-Pyridinecarboxylic acid, 3-broMo-6-chloro-, 1,1-diMethylethyl ester;tert-butyl 3-bromo-6-chloropyridine-2-carboxylate;3-Bromo-6-chloro-pyridine-2-carboxylic acid tert-butyl ester
• CAS NO: 1235036-15-3
• Molecular Formula: C₁₀H₁₁BrClNO₂
• Molecular Weight: 293
• Mol File: 1235036-15-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 334.3±37.0 °C(Predicted)
• Appearance: /
• Density: 1.475±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -3.48±0.10(Predicted)
• CAS DataBase Reference: Tert-butyl 3-bromo-6-chloropicolinate(CAS DataBase Reference)
• NIST Chemistry Reference: Tert-butyl 3-bromo-6-chloropicolinate(1235036-15-3)
• EPA Substance Registry System: Tert-butyl 3-bromo-6-chloropicolinate(1235036-15-3)

Safety Data

• RIDADR: UN2811
• Hazardous Substances Data: 1235036-15-3(Hazardous Substances Data)

Usage

Description

Tert-butyl 3-bromo-6-chloropicolinate is a chemical compound with the molecular formula C10H10BrClNO2. It is a derivative of picolinic acid, featuring a tert-butyl group, a bromo substituent at the 3rd position, and a chloro substituent at the 6th position. Tert-butyl 3-bromo-6-chloropicolinate is known for its potential applications in various chemical and pharmaceutical processes due to its unique structural features.

Uses

Used in Chemical Synthesis:
Tert-butyl 3-bromo-6-chloropicolinate is used as an intermediate in the synthesis of various organic compounds, particularly in the expeditious synthesis of isoquinolones and isocoumarins. These synthesized compounds have potential applications in the pharmaceutical industry, as they can be further modified to create new drugs with specific therapeutic properties.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Tert-butyl 3-bromo-6-chloropicolinate is used as a building block for the development of novel drug candidates. Its unique structural features allow for the creation of new molecules with potential therapeutic applications, such as those targeting specific receptors or enzymes in the human body.
Used in Material Science:
The compound may also find applications in material science, where its structural properties can be utilized to develop new materials with specific characteristics, such as improved stability or reactivity under certain conditions.

Upstream product

• 929000-66-8 3-bromo-6-chloropyridine-2-carboxylic acid 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 1430752-51-4 tert-butyl 6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-3-(4-methyl-3-phenoxyphenyl)picolinate 
• 1430752-57-0 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-[3-(cyclohexylmethoxy)-2-methylphenyl]pyridine-2-carboxylic acid tert-butyl ester 
• 1430749-60-2 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-(1-benzyl-1H-1,2,3-triazol-4-yl)pyridine-2-carboxylic acid 
• 1430752-69-4 tert-butyl 6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-3-(1-benzyl-1H-1,2,3-triazol-4-yl)picolinate 
• 1430749-83-9 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-(1-{[3,3-dimethyl-1-(morpholin-4-yl)cyclohexyl]methyl}-5-methyl-1H-pyrazol-4-yl)pyridine-2-carboxylic acid 
• 1430749-95-3 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-{1-[(1-methoxy-3,3-dimethylcyclohexyl)methyl]-5-methyl-1H-pyrazol-4-yl}pyridine-2-carboxylic acid 
• 1430748-53-0 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-[1-(4-chlorobenzyl)-1H-pyrazol-4-yl]pyridine-2-carboxylic acid 
• 1430750-00-7 N-(1,3-benzothiazol-2-yl)-2-(5-{1-[(1-methoxy-3,3-dimethylcyclohexyl)methyl]-5-methyl-1H-pyrazol-4-yl}-6-[(methylsulfonyl)carbamoyl]pyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline-8-carboxamide 
• 1430750-23-4 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-[1-({3,3-dimethyl-1-[2-(methylamino)ethoxy]cyclohexyl}methyl)-5-methyl-1H-pyrazol-4-yl]pyridine-2-carboxylic acid 
• 1430750-27-8 tert-butyl 6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-3-(1-benzyl-1H-pyrazol-4-yl)picolinate 
• 1430748-39-2 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-(1-benzyl-1H-pyrazol-4-yl)pyridine-2-carboxylic acid 
• 1430751-25-9 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-[1-(biphenyl-3-ylmethyl)-1H-pyrazol-4-yl]pyridine-2-carboxylic acid tert-butyl ester 
• 1430749-03-3 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-(1-benzyl-5-phenyl-1H-pyrazol-4-yl)pyridine-2-carboxylic acid 
• 1430749-13-5 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-[1-(diphenylmethyl)-1H-pyrazol-4-yl]pyridine-2-carboxylic acid 

Relevant articles and documents

APOPTOSIS-INDUCING AGENTS

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti apoptotic Bcl-xL protein.

APOPTOSIS-INDUCED AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.

HETEROCYCLIC COMPOUNDS AND METHODS OF USE

In one aspect, the present invention provides for a compound of Formula I; in which the variable X1a, X1b, X1c, X1d, Q, A, R1, B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-xL proteins.